[ Price : $8.95]
The Natural Products Association asks FDA to determine that CBD is recognized as a dietary ingredient.[ Price : $8.95]
FDA Review posts the Federal Register notices for the week ending 2/18/2022.[ Price : $8.95]
Federal Register notice: FDA makes available additional draft and revised draft product-specific guidances that provide recommenda...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension entitled Center for Devices and Radiological He...[ Price : $8.95]
Federal Register notice: FDA classifies the electromechanical tear stimulator into medical device Class 2.[ Price : $8.95]
Federal Register notice: FDA classifies the integrated continuous glucose monitoring system into medical device Class 2.[ Price : $8.95]
Federal Register notice: FDA classifies the percutaneous catheter for creation of an arteriovenous fistula for hemodialysis access...[ Price : $8.95]
FDA extends a clinical hold on BioMarin Pharmaceuticals PHEARLESS Phase 1/2 study of BMN 307, an AAV5-human phenylalanine hydroxyl...